"A team of Howard Hughes Medical Institute (HHMI) researchers 
    has found that in old mice, a several-week exposure to the 
    blood of young mice causes their bone marrow stem cells to 
    act 'young' again."

HHMI.org::Making Old Stem Cells Act Young Again

[01 February 2010, top]

   "We are a data company." Cliff Reid, CEO Complete Genomics

SingularityHub.com::Exclusive: Complete Genomics To Sequence 1 Million Genomes -- Interview With CEO

Just like Google, Complete Genomics, Inc. is located in Mountain View, California.

Complete Genomics scientific advisory board on 27 January 2010.

   Dr. Mark Chee, CEO/CSO of Prognosys Biosciences, Inc. 
   Dr. George Church, Professor of Genetics at Harvard Medical 
       School and Director of the Center for Computational Genetics
   Dr. Leroy Hood, President of the Institute for Systems Biology
   Dr. Douglas A. Lauffenburger, Uncas & Helen Whitaker Professor 
       of Bioengineering and Director of the Biological Engineering 
       Division at MIT, and also holds appointments in the Department 
       of Biology and the Department of Chemical Engineering

CompleteGenomics.com::Powering large-scale human genome studies

[27 January 2010, top]

WashingtonPost.com::Using genetic information to match singles with potential partners

[24 January 2010, top]

	National Geographic: "Merging Man And Machine - A Better 
	Life With Bionics" http://bit.ly/8sWl22

[23 January 2010, top]

   Beyond Legos: Berkeley Lab helps launch first open-source 
   genetic parts production facility http://bit.ly/5zJxmI

Berkeley.edu reported that they are establishing BIOFAB.

   "International Open Facility Advancing Biotechnology (BIOFAB), 
    aims to produce thousands of free, standardized DNA parts to 
    shorten the development time and lower the cost of synthetic 
    biology for academic or biotech laboratories."

Berkeley.edu::NSF grant to launch world's first open-source genetic parts production facility

[21 January 2010, top]

My initial response was: "I'm assuming it would; therefore, I hope so." But... the keyword in my reponse is "hope." In other words, I haven't a clue.

   "The key is to shift from diagnosing patients when they already 
    have symptoms to detecting disease much earlier, before symptoms 
    appear. This is the potential that molecular medicine brings to 
    personalized healthcare delivery. Personalized healthcare will 
    be predictive and preventive, probing an individual's unique 
    biology to assess disease probability and then designing 
    appropriate treatments, even before symptoms."
    --Matthew O'Donnell, Dean of the University of 
      Washington's College of Engineering 

I'm still clueless after reading O'Donnell's article at Xconomy.com, but I'm still hoping that molecular medicine will make significant advances over the span of the next decade.

Xconomy.com::Can Molecular Medicine Survive Its Teenage Years, and Reach its Potential This Decade?

[15 January 2010, top]

   Illumina (nasdaq: ILMN) HiSeq 2000 can sequence a human 
   genome for less than $10K. (pr) http://ow.ly/VZd9

We're living in the Genomics Age and the cost of genome sequencing keeps getting cheaper and cheaper.

[13 January 2010, top]

   "induced pluripotent stem cells" #IPScells 
   ScientificAmerican.com http://ow.ly/S0lK

[03 January 2010, top]

Biotech Trekker Archives: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003-02

[01 January 2010, top]